NCT03241420View on ClinicalTrials.gov

Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease

Active, not recruitingOBSERVATIONAL

Enrollment

600

Participants

Timeline

Start Date

April 24, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Chronic Lung Disease

Interventions

DEVICE

lung clearance index (LCI)

Determine the utility and sensitivity of the lung clearance index (LCI) technique as a marker of lung injury/small airways disease in adults with chronic lung conditions compared to health adults, adjusting for age, sex, and smoking status.

Trial Locations (1)

80206

National Jewish Health, Denver

All Listed Sponsors

lead

National Jewish Health

OTHER

NCT03241420 - Utility of Lung Clearance Index Score As a Noninvasive Marker of Small Airways Disease | Biotech Hunter | Biotech Hunter